Growth Metrics

Cytosorbents (CTSO) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn -136.41%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -136.41%
Dec 31, 2025 -14.80%
Sep 30, 2025 11.85%
Jun 30, 2025 -133.34%
Mar 31, 2025 160.02%
Dec 31, 2024 -140.55%
Sep 30, 2024 40.59%
Jun 30, 2024 183.96%
Mar 31, 2024 -77.95%
Dec 31, 2023 1,137.17%
Sep 30, 2023 35.37%
Jun 30, 2023 53.93%
Mar 31, 2023 65.51%
Dec 31, 2022 92.46%
Sep 30, 2022 -63.36%
Jun 30, 2022 -340.15%
Mar 31, 2022 -213.41%
Dec 31, 2021 56.01%
Sep 30, 2021 -108.66%
Jun 30, 2021 -133.33%
Mar 31, 2021 -120.29%
Dec 31, 2020 -338.70%
Sep 30, 2020 17,468.87%
Jun 30, 2020 360.02%
Mar 31, 2020 623.18%
Dec 31, 2019 -46.95%
Sep 30, 2019 11.76%
Jun 30, 2019 -178.72%
Mar 31, 2019 -171.87%
Dec 31, 2018 -233.35%
Sep 30, 2018 66.72%
Jun 30, 2018 -67.68%
Mar 31, 2018 287.17%
Dec 31, 2017 270.45%
Sep 30, 2017 55.17%
Jun 30, 2017 162.45%
Mar 31, 2017 -22.86%
Dec 31, 2016 46.40%
Sep 30, 2016 -262.02%
Jun 30, 2016 301.40%
Mar 31, 2016 -123.68%
Dec 31, 2015 -163.62%
Sep 30, 2015 86.05%
Jun 30, 2015 -60.90%
Mar 31, 2015 63.43%
Dec 31, 2014 3,901.65%
Sep 30, 2014 -1,138.95%
Jun 30, 2014 -404.62%
Mar 31, 2014 1,270.26%
Dec 31, 2013 72.82%
Sep 30, 2013 37.55%
Jun 30, 2013 926.96%
Mar 31, 2013 -158.67%
Dec 31, 2012 71.24%
Sep 30, 2012 128.50%
Jun 30, 2012 -106.07%
Mar 31, 2012 -55.36%
Dec 31, 2011 -473.01%
Sep 30, 2011 -788.62%